Neupro 8 mg/24 h transdermal patch

Active Ingredient
Strength
  • Rotigotine: 8 mg
Dosage Form
Transdermal patch
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/05/331/10 8 mg N04BC Transdermal patch
EU/1/05/331/11 8 mg N04BC Transdermal patch
EU/1/05/331/12 8 mg N04BC Transdermal patch
EU/1/05/331/32 8 mg N04BC Transdermal patch
EU/1/05/331/33 8 mg N04BC Transdermal patch
EU/1/05/331/34 8 mg N04BC Transdermal patch
EU/1/05/331/35 8 mg N04BC Transdermal patch
EU/1/05/331/36 8 mg N04BC Transdermal patch
EU/1/05/331/37 8 mg N04BC Transdermal patch
Licence number
EU/1/05/331/10
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/11
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/12
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/32
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/33
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/34
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/35
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/36
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch
Licence number
EU/1/05/331/37
Strength
8 mg
ATC Code
N04BC
Dosage Form
Transdermal patch

UCB (Pharma) Ireland Limited

United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland

Telephone
+3531800930075